{"id":452,"date":"2019-04-16T16:24:52","date_gmt":"2019-04-16T14:24:52","guid":{"rendered":"http:\/\/henkjanout.nl\/?p=452"},"modified":"2019-04-16T16:24:53","modified_gmt":"2019-04-16T14:24:53","slug":"pillen-ontwikkelen-met-belastinggeld","status":"publish","type":"post","link":"https:\/\/henkjanout.nl\/en\/pillen-ontwikkelen-met-belastinggeld\/","title":{"rendered":"Pillen ontwikkelen met belastinggeld?"},"content":{"rendered":"<p class=\"s8\"><span class=\"s5\">&#8220;Medicijnen maken kan goedkoper&#8221;, <a href=\"https:\/\/www.nrc.nl\/nieuws\/2019\/03\/18\/medicijnen-maken-kan-goedkoper-a3953704\">kopte<\/a><\/span><span class=\"s5\">\u00a0<\/span><span class=\"s5\">de NRC hoopvol op 18 maart. Farmaceuten geven kapitalen uit voor nieuwe medicijnen en dat hoeft helemaal niet. Althans volgens onderzoeksbureau <a href=\"https:\/\/gallery.mailchimp.com\/aa3dd57dd0ff188a82dbe388e\/files\/400eae54-96f8-42ad-a0c8-6b9bfd3251ba\/The_cost_of_opportunity_Gupta_Strategists.pdf\">Gupta<\/a><\/span><span class=\"s5\">. Emeritus hoogleraar en politicoloog Joost Smiers vindt de farmaceutische industrie zelfs overbodig, zo <a href=\"https:\/\/www.medischcontact.nl\/nieuws\/laatste-nieuws\/artikel\/farmaceutische-industrie-is-overbodig.htm\">schreef<\/a><\/span><span class=\"s5\">\u00a0<\/span><span class=\"s5\">hij onlangs in Medisch Contact. Laat universiteiten het onderzoek doen, betaald door publieke onderzoeksfondsen en de industrie mag dan later die patentloze middelen produceren voor een lage prijs, betoogt hij. <\/span><\/p>\n<p><!--more--><\/p>\n<p><em>Wie betaalt?<\/em><\/p>\n<p class=\"s8\"><span class=\"s5\">Ook Gupta doet een pleidooi voor publieke investeringen maar om andere redenen. Hun <\/span><span class=\"s5\">rapport<\/span><span class=\"s5\"> bevestig<\/span><span class=\"s5\">t<\/span> <span class=\"s5\">de enorme kosten<\/span><span class=\"s5\"> voor<\/span><span class=\"s5\"> onderzoek en ontwikkeling <\/span><span class=\"s5\">van <\/span><span class=\"s5\">nieuwe geneesmiddelen<\/span><span class=\"s5\">.<\/span><span class=\"s5\"> In totaal <\/span><span class=\"s5\">kost een goedgekeurd middel <\/span><span class=\"s5\">2,5 miljard dollar, waarvan 200 miljoen voor <\/span><span class=\"s5\">het middel zelf <\/span><span class=\"s5\">en 1 miljard voor de mislukkingen. Maar de grootste kostenpost <\/span><span class=\"s5\">betr<\/span><span class=\"s5\">eft<\/span><span class=\"s5\"> de kapitaalkosten<\/span><span class=\"s5\"> van<\/span><span class=\"s5\"> 1,3 miljard, als gevolg van de hoge rendementseisen van beleggers en de zeer lange duur van ontwikkeling. De oplossing: publiek financieren want de belastingbetaler eist geen hoge rendementen<\/span><span class=\"s5\">,<\/span><span class=\"s5\"> en <\/span><span class=\"s5\">daarnaast <\/span><span class=\"s5\">m<\/span><span class=\"s5\">iddelen eerder op de markt toelaten. In beide gevallen nemen de kapitaalkosten<\/span><span class=\"s5\"> en kosten van ontwikkeling<\/span><span class=\"s5\"> af. Maar zoals wel vaker in dit dossier zijn de geboden oplossingen niet erg realistisch.<\/span><\/p>\n<p><em>Realistisch?<\/em><\/p>\n<p class=\"s4\"><span class=\"s5\">In de eerste plaats: Wie gaat die miljarden <\/span><span class=\"s5\">in die publieke onderzoeksfondsen opbrengen<\/span><span class=\"s5\">? Inderdaad, het publiek, U en ik. Een gemiddelde late<\/span><span class=\"s5\">,<\/span><span class=\"s5\"> fase III <\/span><span class=\"s9\">random<\/span><span class=\"s9\">ized<\/span><span class=\"s9\"> c<\/span><span class=\"s9\">ontrolled<\/span><span class=\"s9\"> trial<\/span><span class=\"s5\"> (RCT)<\/span><span class=\"s5\"> kost <a href=\"http:\/\/www.evaluate.com\/products-services\/pharma\/evaluatepharma-vision?utm_source=Twitter&amp;utm_medium=Social&amp;utm_campaign=evaluatepharma\">159 miljoen dollar<\/a> en dan duurt het nog zo&#8217;n 3,5 jaar voordat de registratieautoriteiten<\/span><span class=\"s5\"> een middel toelaten<\/span><span class=\"s5\">. Geen politicus gaat de verkiezingen winnen met een campagne om dit soort bedragen maar <\/span><span class=\"s5\">uit<\/span> <span class=\"s5\">de schatkist te onttrekken. Bovendien <\/span><span class=\"s5\">faalt de helft van die studies<\/span><span class=\"s5\">, <\/span><span class=\"s5\">want <\/span><span class=\"s5\">die nieuwe geneesmiddelen werken <\/span><span class=\"s5\">soms <\/span><span class=\"s5\">niet of er zijn onacceptable veiligheidsrisico\u2019s<\/span><span class=\"s5\">. <\/span><span class=\"s5\">Die 159 miljoen <\/span><span class=\"s5\">aan belastinggeld is<\/span><span class=\"s5\"> dan <\/span><span class=\"s9\">down the drain<\/span><span class=\"s9\">.<\/span><\/p>\n<p class=\"s4\"><em><span class=\"s9\">Vroege toelating<\/span><\/em><\/p>\n<p class=\"s4\"><span class=\"s5\">De andere oplossing, <\/span><span class=\"s5\">vroege toelating <\/span><span class=\"s5\">tot de markt en <\/span><span class=\"s5\">dure <\/span><span class=\"s5\">RCT\u2019s <\/span><span class=\"s5\">vervangen door observationale studies in de klinische praktijk, <\/span><span class=\"s5\">zogenaamd <\/span><span class=\"s9\">real-world evidence<\/span><span class=\"s5\"> (RWE) onderzoek,<\/span><span class=\"s5\"> betekent dus dat we<\/span><span class=\"s5\">toestaan <\/span><span class=\"s5\">dat de helft van die nieuwe <\/span><span class=\"s5\">geneesmiddelen <\/span><span class=\"s5\">die we dan <\/span><span class=\"s5\">voorschrijven <\/span><span class=\"s5\">niet werkt<\/span><span class=\"s5\"> of onveilig is<\/span><span class=\"s5\">. <\/span><span class=\"s9\">Real-<\/span><span class=\"s9\">w<\/span><span class=\"s9\">o<\/span><span class=\"s9\">r<\/span><span class=\"s9\">ld evidence<\/span><span class=\"s5\"> is <\/span><span class=\"s5\">natuurlijk <\/span><span class=\"s5\">belangrijk <\/span><span class=\"s5\">maar heeft <\/span><span class=\"s5\">nooit dezelfde bewijskracht als <\/span><span class=\"s5\">een <\/span><span class=\"s5\">RCT. Geen zorgautoriteit zal erover peinzen om <\/span><span class=\"s5\">al deze <\/span><span class=\"s5\">middelen te vergoeden zonder robuust bewijs<\/span><span class=\"s5\">, zelfs niet tijdelijk<\/span><span class=\"s5\">.<\/span> <span class=\"s5\">In veel gevallen vin<\/span><span class=\"s5\">d<\/span><span class=\"s5\">t<\/span><span class=\"s5\"> het Zorginstituut het bewijs uit <\/span><span class=\"s5\">fase III <\/span><span class=\"s5\">RCT\u2019s<\/span><span class=\"s5\"> al onvoldoende<\/span> <span class=\"s5\">om een geneesmiddel in het basispakket op te nemen<\/span><span class=\"s5\">. <\/span><span class=\"s5\">B<\/span><span class=\"s5\">ij <\/span><span class=\"s5\">levensreddende middelen kan dit <\/span><span class=\"s5\">soms <\/span><span class=\"s5\">een uitweg zijn, maar <\/span><span class=\"s5\">dat zijn uitzonderlijke gevallen<\/span><span class=\"s5\">. <\/span><\/p>\n<p class=\"s4\"><em><span class=\"s9\">Antibiotica<\/span><\/em><\/p>\n<p class=\"s4\"><span class=\"s5\">Laten we ophouden te denken dat de overheid het goedkoper kan<\/span><span class=\"s5\">. Risicovolle investeringen moeten gedaan worden met privaat geld. Die investeerders eisen terecht hoge rendementen en dus zullen de prijzen <\/span><span class=\"s5\">hoog zijn <\/span><span class=\"s5\">gedurende<\/span><span class=\"s5\"> de korte tijd dat een monopolie <\/span><span class=\"s5\">van toepassing is.<\/span><span class=\"s5\"> Maar publiek geld is wel nodi<\/span><a name=\"_GoBack\"><\/a><span class=\"s5\">g als de markt faalt, bijvoorbeeld in het geval van antibiotica. <\/span><span class=\"s5\">Laten we daar beginnen: er <\/span><span class=\"s5\">is<\/span><span class=\"s5\"> een grote medische <\/span><span class=\"s5\">behoefte aan<\/span><span class=\"s5\">,<\/span><span class=\"s5\"> maar <\/span><span class=\"s5\">duur <\/span><span class=\"s5\">onderzoek naar <\/span><span class=\"s5\">nieuwe <\/span><span class=\"s5\">antibiotica<\/span><span class=\"s5\"> die <\/span><span class=\"s5\">artsen <\/span><span class=\"s5\">alleen als laatste redmiddel <\/span><span class=\"s5\">moeten <\/span><span class=\"s5\">voorschrijven <\/span><span class=\"s5\">is per definitie verliesgevend<\/span><span class=\"s5\">. Al jaren roept men om overheidsbemoeienis om uit dit dilemma te komen en hier ligt <\/span><span class=\"s5\">dus <\/span><span class=\"s5\">een prachtige mogelijkheid voor publiek-private samenwerking. Zo<\/span><span class=\"s5\">la<\/span><span class=\"s5\">ng dat al niet eens van de grond komt, denk ik <\/span><span class=\"s5\">niet dat<\/span><span class=\"s5\"> de voorstellen van Smiers en Gupta ook maar enige kans maken.<\/span><\/p>\n<p class=\"bawpvc-ajax-counter\" data-id=\"452\"> (261 keer gelezen)<\/p>\n<p><!-- AddThis Advanced Settings generic via filter on the_content --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Medicijnen maken kan goedkoper&#8221;, kopte\u00a0de NRC hoopvol op 18 maart. Farmaceuten geven kapitalen uit voor nieuwe medicijnen en dat hoeft helemaal niet. Althans volgens onderzoeksbureau Gupta. Emeritus hoogleraar en politicoloog Joost Smiers vindt de farmaceutische industrie zelfs overbodig, zo schreef\u00a0hij &hellip; <a href=\"https:\/\/henkjanout.nl\/en\/pillen-ontwikkelen-met-belastinggeld\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><!-- AddThis Advanced Settings generic via filter on wp_trim_excerpt --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"translation":{"provider":"WPGlobus","version":"3.0.2","language":"en","enabled_languages":["nl","en"],"languages":{"nl":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pillen ontwikkelen met belastinggeld? | Henk Jan Out<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pillen ontwikkelen met belastinggeld? | Henk Jan Out\" \/>\n<meta property=\"og:url\" content=\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/\" \/>\n<meta property=\"og:site_name\" content=\"Henk Jan Out\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-16T14:24:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-04-16T14:24:53+00:00\" \/>\n<meta name=\"author\" content=\"Henk Jan Out\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Henkjanout\" \/>\n<meta name=\"twitter:site\" content=\"@Henkjanout\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Henk Jan Out\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/\"},\"author\":{\"name\":\"Henk Jan Out\",\"@id\":\"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec\"},\"headline\":\"Pillen ontwikkelen met belastinggeld?\",\"datePublished\":\"2019-04-16T14:24:52+00:00\",\"dateModified\":\"2019-04-16T14:24:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/\"},\"wordCount\":546,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec\"},\"articleSection\":[\"Geen categorie\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/\",\"url\":\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/\",\"name\":\"Pillen ontwikkelen met belastinggeld? | Henk Jan Out\",\"isPartOf\":{\"@id\":\"https:\/\/henkjanout.nl\/en\/#website\"},\"datePublished\":\"2019-04-16T14:24:52+00:00\",\"dateModified\":\"2019-04-16T14:24:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/henkjanout.nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pillen ontwikkelen met belastinggeld?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/henkjanout.nl\/en\/#website\",\"url\":\"https:\/\/henkjanout.nl\/en\/\",\"name\":\"Henk Jan Out\",\"description\":\"Pharmaceutical physician, writer, consultant\",\"publisher\":{\"@id\":\"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/henkjanout.nl\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec\",\"name\":\"Henk Jan Out\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/henkjanout.nl\/wp-content\/uploads\/2016\/06\/image-4.jpeg\",\"contentUrl\":\"https:\/\/henkjanout.nl\/wp-content\/uploads\/2016\/06\/image-4.jpeg\",\"width\":512,\"height\":512,\"caption\":\"Henk Jan Out\"},\"logo\":{\"@id\":\"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Henkjanout\"],\"url\":\"https:\/\/henkjanout.nl\/en\/author\/henkjanout\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pillen ontwikkelen met belastinggeld? | Henk Jan Out","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/","og_locale":"en_US","og_type":"article","og_title":"Pillen ontwikkelen met belastinggeld? | Henk Jan Out","og_url":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/","og_site_name":"Henk Jan Out","article_published_time":"2019-04-16T14:24:52+00:00","article_modified_time":"2019-04-16T14:24:53+00:00","author":"Henk Jan Out","twitter_card":"summary_large_image","twitter_creator":"@Henkjanout","twitter_site":"@Henkjanout","twitter_misc":{"Written by":"Henk Jan Out","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#article","isPartOf":{"@id":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/"},"author":{"name":"Henk Jan Out","@id":"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec"},"headline":"Pillen ontwikkelen met belastinggeld?","datePublished":"2019-04-16T14:24:52+00:00","dateModified":"2019-04-16T14:24:53+00:00","mainEntityOfPage":{"@id":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/"},"wordCount":546,"commentCount":0,"publisher":{"@id":"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec"},"articleSection":["Geen categorie"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/","url":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/","name":"Pillen ontwikkelen met belastinggeld? | Henk Jan Out","isPartOf":{"@id":"https:\/\/henkjanout.nl\/en\/#website"},"datePublished":"2019-04-16T14:24:52+00:00","dateModified":"2019-04-16T14:24:53+00:00","breadcrumb":{"@id":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/henkjanout.nl\/pillen-ontwikkelen-met-belastinggeld\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/henkjanout.nl\/"},{"@type":"ListItem","position":2,"name":"Pillen ontwikkelen met belastinggeld?"}]},{"@type":"WebSite","@id":"https:\/\/henkjanout.nl\/en\/#website","url":"https:\/\/henkjanout.nl\/en\/","name":"Henk Jan Out","description":"Pharmaceutical physician, writer, consultant","publisher":{"@id":"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/henkjanout.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/f6f01033a23ed3e09b979c4bf2503aec","name":"Henk Jan Out","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/image\/","url":"https:\/\/henkjanout.nl\/wp-content\/uploads\/2016\/06\/image-4.jpeg","contentUrl":"https:\/\/henkjanout.nl\/wp-content\/uploads\/2016\/06\/image-4.jpeg","width":512,"height":512,"caption":"Henk Jan Out"},"logo":{"@id":"https:\/\/henkjanout.nl\/en\/#\/schema\/person\/image\/"},"sameAs":["https:\/\/x.com\/Henkjanout"],"url":"https:\/\/henkjanout.nl\/en\/author\/henkjanout\/"}]}},"_links":{"self":[{"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/posts\/452"}],"collection":[{"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/comments?post=452"}],"version-history":[{"count":1,"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/posts\/452\/revisions"}],"predecessor-version":[{"id":453,"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/posts\/452\/revisions\/453"}],"wp:attachment":[{"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/media?parent=452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/categories?post=452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/henkjanout.nl\/en\/wp-json\/wp\/v2\/tags?post=452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}